Penumbra (PEN) Valuation Update After Needham Upgrade and Strong Growth Catalysts for 2026

Simply Wall St.

Oct 24, 2025

On October 8, Needham upgraded Penumbra (PEN) to Buy, highlighting several key developments expected to accelerate growth in 2026. New product launches, trial results, and improving conditions in ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2578541560"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2578541560\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2578541560?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","is_english":true,"pubTime":"2025-10-24 22:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578541560","market":"hk","top_or_hot":-1,"title":"Penumbra (PEN) Valuation Update After Needham Upgrade and Strong Growth Catalysts for 2026","media":"Simply Wall St.","content":"<div>\n<p>On October 8, Needham upgraded Penumbra (PEN) to Buy, highlighting several key developments expected to accelerate growth in 2026. New product launches, trial results, and improving conditions in ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-pen-valuation-update-after-needham-upgrade-and-stro\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Penumbra (PEN) Valuation Update After Needham Upgrade and Strong Growth Catalysts for 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPenumbra (PEN) Valuation Update After Needham Upgrade and Strong Growth Catalysts for 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-24 22:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-pen-valuation-update-after-needham-upgrade-and-stro><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On October 8, Needham upgraded Penumbra (PEN) to Buy, highlighting several key developments expected to accelerate growth in 2026. New product launches, trial results, and improving conditions in ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-pen-valuation-update-after-needham-upgrade-and-stro\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PEN","symbol_name":"Penumbra Inc","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-pen-valuation-update-after-needham-upgrade-and-stro","article_id":"2578541560","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-pen/penumbra/news/penumbra-pen-valuation-update-after-needham-upgrade-and-stro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2578541560","pubTimestamp":1761316251,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"On October 8, Needham upgraded Penumbra (PEN) to Buy, highlighting several key developments expected to accelerate growth in 2026. New product launches, trial results, and improving conditions in China are driving the shift.\nSee our latest analysis for Penumbra.\nPenumbra’s shares have seen renewed interest after recent product milestones and the Needham upgrade, with a nearly 9% share price return over the last three months helping to lift year-to-date momentum. Looking at a longer time...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"PEN":"Penumbra Inc","PEN.AU":"PENINSULA ENERGY LTD"},"translate_title":"Needham升级后Penumbra(PEN)估值更新以及2026年强劲增长催化剂","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEN":1.5,"PEN.AU":1.5},"content_text":"On October 8, Needham upgraded Penumbra (PEN) to Buy, highlighting several key developments expected to accelerate growth in 2026. New product launches, trial results, and improving conditions in China are driving the shift.\nSee our latest analysis for Penumbra. Penumbra’s shares have seen renewed interest after recent product milestones and the Needham upgrade, with a nearly 9% share price return over the last three months helping to lift year-to-date momentum. Looking at a longer time frame, its total shareholder return of almost 23% over the past year highlights the strong longer-term recovery, even though five-year returns are still slightly negative. If Penumbra's rebound has you thinking bigger, this could be the perfect moment to broaden your search and discover See the full list for free. With Penumbra trading nearly 20% below analyst price targets and growth drivers gaining traction, investors must now ask if the recent momentum signals an undervalued entry point or if the market is already pricing in the upside. AdvertisementMost Popular Narrative: 16.4% Undervalued With Penumbra’s last close at $253.51 and a consensus fair value estimate near $303, the narrative signals that the market may be missing key upside drivers. The setup centers on pivotal catalysts that could reshape Penumbra’s competitive landscape.  The soon-to-be-released STORM-PE randomized trial is poised to provide Level 1 evidence comparing Penumbra's thrombectomy technology to standard anticoagulation for pulmonary embolism. A positive outcome could expand guideline adoption, significantly accelerate procedure volumes, and drive substantial revenue growth by rapidly increasing penetration in a very underpenetrated, large market.  Read the complete narrative. Curious how much future profit acceleration is baked into that fair value? The narrative is powered by bold assumptions on breakthrough growth, margin expansion, and an aggressive forward profit multiple rarely seen in the sector. What is the full story behind these punchy projections? Unpack the details by reading the complete narrative. Result: Fair Value of $303 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, challenges remain, as intensified competition and regulatory scrutiny in international markets could quickly disrupt Penumbra’s growth trajectory and impact earnings momentum. Find out about the key risks to this Penumbra narrative. Another View: Looking at Valuation from a Different Angle Shifting away from future earnings forecasts, a quick check of Penumbra’s current price-to-earnings ratio tells a different story. At 66.9x, it stands well above the peer average of 32x and the industry’s 30.2x, and even further above the fair ratio of 27.9x. This suggests the stock is priced for significant growth, raising the question: are these lofty expectations justified, or is there valuation risk the market is ignoring? See what the numbers say about this price — find out in our valuation breakdown. NYSE:PEN PE Ratio as at Oct 2025 Build Your Own Penumbra Narrative If you have a different perspective, or would rather dive into the numbers yourself, you can easily craft your own outlook in just a few minutes. Do it your way A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Penumbra. Looking for More Investment Ideas? Smart investors always keep an eye on new opportunities. Don’t let a great investment slip by. Expand your horizons with these handpicked stock ideas now:  Hunt for hidden value by checking out these 875 undervalued stocks based on cash flows with attractive valuations and strong growth potential that others often overlook. Tap into game-changing innovation when you research these 27 quantum computing stocks, where real advancements in quantum computing could reshape whole industries. Supercharge your returns by following these 17 dividend stocks with yields > 3% that pay robust yields above 3%, adding steady income to your portfolio.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}